Ipsen Stock price

Equities

IPN

FR0010259150

Pharmaceuticals

Market Closed - Euronext Paris 12:35:52 2024-03-28 pm EDT After market 04:59:58 pm
110.3 EUR +1.01% Intraday chart for Ipsen 110.4 +0.09%
Sales 2024 * 3.45B 3.72B Sales 2025 * 3.7B 3.99B Capitalization 9.02B 9.72B
Net income 2024 * 647M 698M Net income 2025 * 725M 782M EV / Sales 2024 * 2.44 x
Net cash position 2024 * 594M 640M Net cash position 2025 * 1.21B 1.3B EV / Sales 2025 * 2.11 x
P/E ratio 2024 *
13.9 x
P/E ratio 2025 *
12.5 x
Employees 5,325
Yield 2024 *
1.09%
Yield 2025 *
1.11%
Free-Float 41.52%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.92%
1 week+1.19%
Current month+8.25%
1 month+8.46%
3 months+2.32%
6 months-10.11%
Current year+2.13%
More quotes
1 week
107.60
Extreme 107.6
110.30
1 month
99.70
Extreme 99.7
110.30
Current year
99.70
Extreme 99.7
110.60
1 year
99.70
Extreme 99.7
130.70
3 years
68.15
Extreme 68.15
130.70
5 years
34.20
Extreme 34.2
130.70
10 years
28.24
Extreme 28.235
155.95
More quotes
Managers TitleAgeSince
Chief Executive Officer 57 20-06-30
Director of Finance/CFO 54 14-11-02
Chairman 66 10-11-21
Members of the board TitleAgeSince
Director/Board Member 61 22-01-20
Director/Board Member 65 15-05-26
Chairman 66 10-11-21
More insiders
Date Price Change Volume
24-03-28 110.3 +1.01% 106 351
24-03-27 109.2 +0.83% 51,965
24-03-26 108.3 -1.10% 69,726
24-03-25 109.5 +0.37% 61,465
24-03-22 109.1 +0.18% 119,187

Real-time Euronext Paris, March 28, 2024 at 05:38 am EDT

More quotes
Ipsen specialises in the research, development, manufacture and marketing of specialty medicines. Net sales by therapeutic area break down as follows: - oncology (78.6%); - neuroscience (20%); - rare diseases (1.4%). At the end of 2022, the group had 4 research and development centres located in France, the United Kingdom, the United States and China, and 4 manufacturing sites worldwide. Net sales (excluding divested operations) are distributed geographically as follows: Europe (40.9%), North America (34.1%) and other (25%). In July 2022, the group divested its family health products manufacturing business.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
109.2 EUR
Average target price
124.8 EUR
Spread / Average Target
+14.31%
Consensus
  1. Stock
  2. Equities
  3. Stock Ipsen - Euronext Paris